Skip to main content
Home
  • The Legislative Assembly meets on 16/04/2024 (01:00 PM)
    Assembly sit 16/04/2024
  • The Legislative Council meets on 16/04/2024 (01:00 PM)
    Council sit 16/04/2024
  • The Public Administration meets on 08/04/2024 (10:00 AM)
    Committee meet 08/04/2024

Parliamentary Questions


Question Without Notice No. 377 asked in the Legislative Council on 11 May 2022 by Hon Donna Faragher

Parliament: 41 Session: 1

GESTATIONAL TROPHOBLASTIC DISEASE

377. Hon DONNA FARAGHER to the Leader of the House representing Minister for Health:

I refer to the Department of Health and gestational trophoblastic disease.

(1) In 2020 and 2021, how many women were diagnosed with this disease?

(2) Can the minister advise whether a gestational trophoblastic disease registry currently exists in Western Australia?

(3) If no to (2), please advise what specific treatment, monitoring and management programs are currently available to women who have been diagnosed with this disease, and include details on which facilities these services can be accessed from?

Hon SUE ELLERY replied:

I thank the honourable member for some notice of the question. I am going to do my best to pronounce the words I am required to say. I apologise to those people for whom this is a serious issue if I cannot say them properly.

(1) The Women and Newborn Health Service would need to undertake a retrospective audit to provide these numbers and would require additional notice and time to do this.

�(2) No.

(3) King Edward Memorial Hospital for Women clinical practice guidelines on pregnancy care are followed. Following discharge, the patient's general practitioner is informed. Follow-up is provided either by the GP or at King Edward Memorial Hospital outpatient clinic and counselling is provided to the patient. For each pregnancy after diagnosis, the patient's beta human chorionic gonadotropin tests are performed every six weeks.